A recent study reports that a new #immunotherapy using autologous #TCellTherapy targeting multiple #TumorAntigens has shown promising safety and clinical effects in a first-in-human phase 1/2 #ClinicalTrial for #PancreaticCancer.
#PancreaticCancerTreatment
#PancreaticCancerTreatment
Autologous T cell therapy targeting multiple antigens shows promise treating pancreatic cancer – BioNews Central
A recent study reports that a new immunotherapy using autologous T cell therapy targeting multiple tumor antigens has shown promising safety and clinical effects in a first-in-human phase 1/2 trial for pancreatic cancer. ...
sbee.link
January 14, 2026 at 12:41 AM
A recent study reports that a new #immunotherapy using autologous #TCellTherapy targeting multiple #TumorAntigens has shown promising safety and clinical effects in a first-in-human phase 1/2 #ClinicalTrial for #PancreaticCancer.
#PancreaticCancerTreatment
#PancreaticCancerTreatment